OCGN:NASDAQ
Ocugen Inc
$1.02
arrow_downward
-0.49%(-0.0050) 1D
$1.04
arrow_upward
+1.96% (+0.020)bedtimeAfter hours
Closed: Sep 11, 4:00:00โฏPM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCGN...
Open
$1.04
High
$1.06
Low
$1.01
Mkt. cap
347.59M
Avg. vol.
5.53M
Volume
6.47M
52-wk high
$2.72
52-wk low
$1.01
EPS
-$0.25
Beta
2.20
Shares outstanding
339.11M
No. of employees
116
Open
$1.04
High
$1.06
Low
$1.01
Mkt. cap
347.59M
Avg. vol.
5.53M
Volume
6.47M
52-wk high
$2.72
52-wk low
$1.01
EPS
-$0.25
Beta
2.20
Shares outstanding
339.11M
No. of employees
116
News stories
From web sources and news partners
ad-hoc-news.de
·
29 minutes ago
Ocugen CEO Trims Stake by 9.46% as Shares Sit 62% Below Their Yearly Peak
ad-hoc-news.de
·
2 hours ago
Ocugen CEO's September Share Sale Lands in a Sector Gripped by Binary Bets
Investing.com
·
6 hours ago
Ocugen CEO Musunuri sells $589,109 in shares, priced $1.06-$1.31
Seeking Alpha
·
19 hours ago
Ocugen: Q3 Data Catalyst In Stargardt Disease Feels Critical (NASDAQ:OCGN)
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteocugen.com